National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$23.00
add to cart

Rights & Permissions

topleft topright

Marijuana As Medicine?: The Science Beyond the Controversy (2000)
Institute of Medicine (IOM)

Citation Manager

Mack, Alison, Joy, Janet. "Index." Marijuana As Medicine?: The Science Beyond the Controversy. Washington, DC: The National Academies Press, 2000.

Please select a format:

BibTeX EndNote RefMan


Page
188
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


MARIJUANA AS MEDICINE?: The Science Beyond the Controversy

Alternative medicine, general, 11

historical perspectives, 13-14, 24

Alzheimer's disease, 121-122, 145, 150

American Medical Association, 17, 158, 178-179, 180

Amotivational syndrome, 60-61, 178-179

Anandamide, 29, 35, 141

Animal studies, 13, 53, 150

cannabinoids, general, 43-44

carcinogenic effects of smoking marijuana, 42-43

dystonia, 117

historical perspectives, 15-16

Huntington's disease, 117

immune system, 35, 44

muscle spasticity/multiple sclerosis, 35, 107, 110, 112

pain palliation, 33, 51, 79

psychomotor behavior, 31

in regulatory process, 134, 136

reproductive system, 45-46

smoking of marijuana, 42-43, 51

tolerance, 50-51

withdrawal, 52

Anorexia,

see Appetite;

Wasting syndrome

Antioxidants, 31, 151

Anxiety, 11, 24, 58, 61, 62, 96, 113, 174, 183

clinical trials, 74, 84, 87, 91, 92, 93, 109, 119, 143

THC, 108, 109, 111-113

tobacco smokers, 41

withdrawal, 52

Appetite, 174

Alzheimer's disease, 122, 145

cancer and, 101-102

clinical studies, 75, 93, 176

megestrol acetate, 89, 101-102

patients' views, 20, 23, 96

withdrawal, 51

see also AIDS wasting

Arizona, 4, 164

Attitudes

adolescents, 66-67

amotivational syndrome, 60-61, 178-179

illegality of marijuana, 24-25, 42

parental, 55

patients, 19-25, 87, 95-96, 100, 103-104, 108-109, 164

peer pressure, 54, 55, 63

physicians, 21

public opinion, 24-25, 42, 62, 149

users of marijuana, general, 19, 54;

see also “patients” supra

B

Bakalar, James, 19, 74-75

Birth weight, 38, 46

Black persons,

see African Americans

Brain, 59-60, 96-97, 115-116, 118

Alzheimer's disease, 121-122

cannabinoid receptors, 28, 31, 32, 51, 77-78, 83, 98, 107, 109, 117-118, 131-132, 152, 176, 181

Marinol, 143

serotonin, 29, 88, 98, 100

cognitive functions, general, 47, 59-60, 92, 119, 143;

see also Psychological effects;

“memory” infra

craving, 53, 54

epilepsy, 120-121, 134

headaches, 19, 22, 23, 77, 83, 164

pain, general, 77-78

memory, 31, 32-33, 50, 51, 59, 61, 84, 119, 121-122, 152, 176

multiple sclerosis, 107

muscle spasticity, 107

reward system, 53

Britain,

see United Kingdom

Bronchi, 40-41

Buyers' clubs,

see Cannabis buyers' clubs

Page
188